New Market Research Report: Bioabsorbable Scaffolds - US Analysis and Market Forecasts

Coronary artery disease (CAD) and peripheral artery disease (PAD) are global public health and socioeconomic issues that affect millions of lives each year. Bioabsorbable scaffolds (BAS), which provide transient support to the vessel, are viable alternatives to permanent drug-eluting stents (DES) and bare metal stents (BMS) implants. In the report, BAS are defined as fully-bioabsorbable devices that are used in stenting procedures that completely disappear from the target vessel overtime. Stents such as BioMatrix Flex by Biosensors International and Synergy by Boston Scientific Corporation are not included in the report because they are metallic DES with bioabsorbable polymer coatings. Absorption of the bioabsorbable polymer coating still leaves behind a permanent BMS inside the vessel.

This report focuses on the future US Market, as BASs are currently unavailable. This report identifies the unmet needs in the market, provides an understanding of physician perception of BAS, and evaluates the adoption of BAS in the future. Large-scale, long-term studies need to be conducted to demonstrate their clinical efficacy, and once approved new stent technologies need to be integrated appropriately into the existing reimbursement systems within the US before widespread adoption will be seen. To successfully market BAS, companies need to design novel scaffold platforms that address the current unmet needs of conventional drug-eluting and BMS, and show superior clinical performance to the stents that are currently marketed and being used in modern clinics.

Full Report Details at
- http://www.fastmr.com/prod/1071049_bioabsorbable_scaffolds_us.aspx?afid=301

*This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase.

Highlights

Key Questions Answered

* What is the current and future market outlook for Bioabsorbable Scaffolds in the US region? What trends are affecting the Bioabsorbable Scaffold market?
* What are the market sizes of each bioabsorbable scaffold segment?
* What clinical factors and technical specifications will influence a physician to use bioabsorbable scaffolds over conventional DES and BMS stents?
* What are unmet needs in the bioabsorbable scaffold market? What are the clinical and non-clinical barriers in this space?

Reasons to Get this Report

* "What Physicians Think" quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading physicians and other stakeholders from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Companies Mentioned in this Report: Abbott Vascular, Kyoto Medical Planning Co., Ltd., Arterial Remodeling Technologies, Elixir Medical Corporation, Cardionovum, Reva Medical, OrbusNeich Medical, Amaranth Medical, Biotronik, Lepu Medical Technology, HuaAn Biotechnology Co., Ltd., Lifetech Scientific (Shenzhen) Co., LTD. (Lifetech Shenzhen), Arterius, S3V Vascular Technologies, Tepha Inc., Zorion Medical, Xenogenics Corporation, Meril Life Sciences, Boston Scientific Corporation, Icon Interventional Systems

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- MediPoint: Bioabsorbable Scaffolds - Global Analysis and Market Forecasts
- MediPoint: Coronary Stents - US Analysis and Market Forecasts
- MediPoint: Coronary Stents - APAC Analysis and Market Forecasts
- MediPoint: Coronary Stents - EU Analysis and Market Forecasts
- MediPoint: Coronary Stents - SA Analysis and Market Forecasts